Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04711473 · ClinicalTrials.gov registry record · NA
Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT04711473 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 800 participants.
The verdict
NCT04711473, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.
Interventions
- BEHAVIORAL Choice
- BEHAVIORAL Colonoscopy Only
- BEHAVIORAL FIT Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2022-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04711473
The ClinicalTrials.gov registry entry for NCT04711473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Choice is the first listed.
NCT04711473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04711473 about?
NCT04711473 is a clinical study titled "Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting". This is a 3-arm randomized trial aimed at increasing rates of participation in colorectal cancer (CRC) screening by outreach to patients' homes using choice architecture informed by behavioral science principles.
What is the current status of trial NCT04711473?
This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2021-10-27. Estimated completion is 2022-11-11.
What interventions are being tested in trial NCT04711473?
The interventions under investigation include: Choice (BEHAVIORAL), Colonoscopy Only (BEHAVIORAL), FIT Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT04711473?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.